"Cephalosporins/administration and dosage"[MAJR] - Search Results

Year	Number of Results
1965	1
1966	4
1967	13
1968	17
1969	8
1970	30
1971	22
1972	19
1973	17
1974	24
1975	18
1976	16
1977	47
1978	22
1979	22
1980	33
1981	38
1982	46
1983	68
1984	78
1985	38
1986	46
1987	41
1988	81
1989	80
1990	46
1991	71
1992	75
1993	58
1994	53
1995	51
1996	41
1997	43
1998	34
1999	45
2000	63
2001	48
2002	40
2003	53
2004	38
2005	41
2006	53
2007	67
2008	63
2009	51
2010	55
2011	56
2012	70
2013	82
2014	82
2015	91
2016	78
2017	70
2018	84
2019	100
2020	75
2021	44
2022	5
2023	1
2024	1

1

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.

van Duin D, Bonomo RA. van Duin D, et al. Clin Infect Dis. 2016 Jul 15;63(2):234-41. doi: 10.1093/cid/ciw243. Epub 2016 Apr 20. Clin Infect Dis. 2016. PMID: 27098166 Free PMC article. Review.

2

Pharmacokinetic and pharmacodynamic considerations of cephalosporin use in children.

Tauzin M, Ouldali N, Béchet S, Caeymaex L, Cohen R. Tauzin M, et al. Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):869-880. doi: 10.1080/17425255.2019.1678585. Epub 2019 Oct 21. Expert Opin Drug Metab Toxicol. 2019. PMID: 31597049 Review.

3

Cefepime Dosing in Neonates: What is the Evidence?

McDonald D, Shah P. McDonald D, et al. Am J Perinatol. 2021 Jun;38(7):657-661. doi: 10.1055/s-0039-3400312. Epub 2019 Nov 27. Am J Perinatol. 2021. PMID: 31777048 Review.

4

Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.

Kearns GL, Young RA, Jacobs RF. Kearns GL, et al. Clin Pharmacokinet. 1992 Apr;22(4):284-97. doi: 10.2165/00003088-199222040-00004. Clin Pharmacokinet. 1992. PMID: 1606788 Review.

5

Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population.

Corey A, So TY. Corey A, et al. Clin Drug Investig. 2017 Jul;37(7):625-634. doi: 10.1007/s40261-017-0523-2. Clin Drug Investig. 2017. PMID: 28382572 Review.

6

Sequential therapy with intravenous and oral cephalosporins.

Janknegt R, van der Meer JW. Janknegt R, et al. J Antimicrob Chemother. 1994 Jan;33(1):169-77. doi: 10.1093/jac/33.1.169. J Antimicrob Chemother. 1994. PMID: 8157558 Review.

7

Ceftriaxone in febrile neutropenia.

Karthaus M, Cornely OA. Karthaus M, et al. J Chemother. 2003 Jun;15(3):211-9. doi: 10.1179/joc.2003.15.3.211. J Chemother. 2003. PMID: 12868545 Review.

8

New Perspective Enteric-Coated Tablet Dosage Form for Oral Administration of Ceftriaxone: In Vitro and In Vivo Assessments.

Maghrabia AE, Boughdady MF, Meshali MM. Maghrabia AE, et al. AAPS PharmSciTech. 2019 Sep 11;20(7):306. doi: 10.1208/s12249-019-1512-y. AAPS PharmSciTech. 2019. PMID: 31512022

9

Considerations in dosage selection for third generation cephalosporins.

Yuk-Choi JH, Nightingale CH, Williams TW Jr. Yuk-Choi JH, et al. Clin Pharmacokinet. 1992 Feb;22(2):132-43. doi: 10.2165/00003088-199222020-00004. Clin Pharmacokinet. 1992. PMID: 1551290 Review.

10

[Oral cephalosporins].

Kees F. Kees F. Med Monatsschr Pharm. 1992 Jan;15(1):2-10. Med Monatsschr Pharm. 1992. PMID: 1542277 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,629 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,629 results

Results by year